Your browser doesn't support javascript.
loading
A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients.
Hu, Xilin; Guo, Jing; Shi, Jianguang; Li, Da; Li, Xinjian; Zhao, Weijun.
Afiliación
  • Hu X; Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, 315010, Ningbo, China.
  • Guo J; Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, 315010, Ningbo, China.
  • Shi J; Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, 315010, Ningbo, China.
  • Li D; Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, 315010, Ningbo, China.
  • Li X; Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, 315010, Ningbo, China.
  • Zhao W; Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, 315010, Ningbo, China. Silashdyyy@163.com.
BMC Pulm Med ; 23(1): 223, 2023 Jun 22.
Article en En | MEDLINE | ID: mdl-37349743
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Pulm Med Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Pulm Med Año: 2023 Tipo del documento: Article País de afiliación: China